Miller Fisher Syndrome in the COVID-19 Era – A Novel Target Antigen Calls for Novel Treatment

Although Miller Fisher syndrome cases have been published in this coronavirus disease 2019 (COVID-19) pandemic, anti-GQ1b antibody has not been identified so far. A direct proof of association is not yet available since the exact pathophysiology is not known. Using a proof of contradiction argument,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kajani, Surina, Kajani, Raheem, Huang, Chin-Wei, Tran, Tu, Liu, Antonio K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779142/
https://www.ncbi.nlm.nih.gov/pubmed/33409112
http://dx.doi.org/10.7759/cureus.12424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779142/
https://www.ncbi.nlm.nih.gov/pubmed/33409112
http://dx.doi.org/10.7759/cureus.12424

Ejemplares similares